fk 633 has been researched along with glycyl-prolyl-arginyl-proline in 1 studies
| Studies (fk 633) | Trials (fk 633) | Recent Studies (post-2010) (fk 633) | Studies (glycyl-prolyl-arginyl-proline) | Trials (glycyl-prolyl-arginyl-proline) | Recent Studies (post-2010) (glycyl-prolyl-arginyl-proline) |
|---|---|---|---|---|---|
| 19 | 0 | 1 | 57 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzoska, T; Mogami, H; Sano, H; Suzuki, Y; Urano, T | 1 |
1 other study(ies) available for fk 633 and glycyl-prolyl-arginyl-proline
| Article | Year |
|---|---|
Binding of thrombin-activated platelets to a fibrin scaffold through α(IIb)β₃ evokes phosphatidylserine exposure on their cell surface.
Topics: Blood Coagulation; Blood Platelets; Cytochalasin B; Dipeptides; Fibrin; Humans; Microscopy, Confocal; Oligopeptides; Phosphatidylserines; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin | 2013 |